Evidence map›Paper›PMID 27760677›Full record

ReviewGlobal health action

Challenges in diabetes mellitus type 2 management in Nepal: a literature review.

Bishal Gyawali, Alessandra Ferrario, Edwin van Teijlingen, Per Kallestrup

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Global health action. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06623006 (Self Management of Type 2 Diabetes Using a Co-designed Mobile Health), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06623006 naactive not recruitingnot on this map

Self Management of Type 2 Diabetes Using a Co-designed Mobile Health (Mhealth) Intervention in Nepal: A Randomized Control Trial

TypeinterventionalSponsorUniversity of HuddersfieldRan2025 to 2026Enrolled154ConditionsType 2 Diabetes Mellitus (T2DM)Armsmobile health (mhealth)
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Predictor factors of uncontrolled diabetes.BMC endocrine disorders · 2025
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Bishal GyawaliCenter for Global Health, Department of Public Health, Aarhus University, Aarhus, Denmark.
Alessandra FerrarioLSE Health, London School of Economics and Political Science, London, United Kingdom.
Edwin van TeijlingenFaculty of Health & Social Sciences, Bournemouth University, Dorset, United Kingdom.
Per KallestrupCenter for Global Health, Department of Public Health, Aarhus University, Aarhus, Denmark.
Aarhus University · DKBournemouth University · GBLondon School of Economics and Political Science · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesDiabetes has become an increasingly prevalent and severe public health problem in Nepal. The Nepalese health system is struggling to deliver comprehensive, quality treatment and services for diabetes at all levels of health care. This study aims to review evidence on the prevalence, cost and treatment of diabetes mellitus type 2 and its complications in Nepal and to critically assess the challenges to be addressed to contain the epidemic and its negative economic impact.

designA comprehensive review of available evidence and data sources on prevalence, risk factors, cost, complications, treatment, and management of diabetes mellitus type 2 in Nepal was conducted through an online database search for articles published in English between January 2000 and November 2015. Additionally, we performed a manual search of articles and reference lists of published articles for additional references.

resultsDiabetes mellitus type 2 is emerging as a major health care problem in Nepal, with rising prevalence and its complications especially in urban populations. Several challenges in diabetes management were identified, including high cost of treatment, limited health care facilities, and lack of disease awareness among patients. No specific guideline was identified for the prevention and treatment of diabetes in Nepal.

conclusionsWe conclude that a comprehensive national effort is needed to stem the tide of the growing burden of diabetes mellitus type 2 and its complications in Nepal. The government should develop a comprehensive plan to tackle diabetes and other non-communicable diseases supported by appropriate health infrastructure and funding.

Indexed as

costsdiabetes complicationsdiabetes mellitus type 2health carelow-income countryNepal

Identifiers

PMID27760677
PMCPMC5071649
OpenAlexW2535058205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.